News | 20 August 2012
A patent would give Novartis exclusive marketing rights and stop cheaper versions being produced by India's generic drugmakers, who supply medicine to the country's 1.2 billion people and to poorer nations across the world. The case has rekindled ...
Click on the link to read the full article at Reuters India
(This link will open in a new window)